Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.
J.M. Liddell, PhD
Advertisement
J.M.Liddell, PhD, is head of process science at Avecia Biologics Ltd.
Articles by J.M. Liddell, PhD
Advertisement
Latest Updated Articles
Production Strategies for Antibody Fragment TherapeuticsPublished: June 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Celebrating 20 Years of HPLC-CAD Technology
2
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
3
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
4
